Julie Bettinger

Dr. Julie Bettinger is an assistant professor in the Faculty of Medicine, Department of Pediatrics, Division of Infectious and Immunological Diseases at the University of British Columbia. She is funded by the Michael Smith Foundation for Health Research Scholar Award and by grant funding from the Canadian Paediatric Society IMPACT Program.

Bettinger holds operating grants from the Canadian Institutes of Health Research (CIHR), Peter Wall Institute for Advanced Studies, Pfizer, BC Center for Disease Control, and BC Ministry of Health. Trained in infectious disease epidemiology with a PhD from John Hopkins University and a Master of Public Health specializing in international health (also from John Hopkins University), she is part of the Vaccine Evaluation Center located at the Child & Family Research Institute at BC Children’s Hospital.

Bettinger's current research interests include vaccine safety and vaccine preventable diseases, as well as attitudes and beliefs around immunization uptake and use. She is the epidemiologist for the Immunization Monitoring Program, Active (IMPACT) — a national surveillance system for vaccine preventable diseases and vaccine adverse events in 12 pediatric tertiary care centers across Canada. She is the lead investigator for the National Ambulatory Network, which is part of Public Health Agency of Canada/CIHR Influenza Research Network (PCIRN).


Affiliation

University: University of British Columbia
Faculty: Medicine
Department: Pediatrics
Division: Infectious and Immunological Diseases 
Position: Assistant Professor
Research Location: Child & Family Research Institute


Recent Publications

Bettinger JA, Scheifele DW, Le Saux N, Halperin SA, Vaudry W, Tsang R. The disease burden of invasive meningococcal serogroup B disease in Canada. PIDJ 2013; 32(1) e20-e25.

Hoist J, Nøkleby H, Bettinger JA. Considerations for controlling invasive meningococcal disease in high income countries. Vaccine 2012; 30S:B57-B62.

Bettinger JA, Scheifele DW, Halperin SA, Kellner JD, Vanderkooi OG, Schryvers A, De Serres G, Alcantara J. Evaluation of meningococcal serogroup C conjugate vaccine programs in Canadian children: Interim analysis. Vaccine 2012; 30:4023-27.

Halperin SA, Bettinger JA, Greenwood B, Harrison LH, Jelfs J, Ladhani SN, McIntyre P, Ramsay ME, Sáfadi MA. The changing and dynamic epidemiology of meningogoccal disease. Vaccine 2012; 30Suppl2:B26-36.

Dube E, Bettinger JA, Halperin B, Bradet R, Lavoie F, Sauvageau C, Gilca V, Boulianne N. Determinants of parents’ decision to vaccinate their children against rotavirus: results of a longitudinal study. Health Education Research 2012.